Diagnostic and prognostic potential of serum miR-7, miR-16, miR-25, miR-93, miR-182, miR-376a and miR-429 in ovarian cancer patients.

作者: Xiaodan Meng , Simon A Joosse , Volkmar Müller , Fabian Trillsch , Karin Milde-Langosch

DOI: 10.1038/BJC.2015.340

关键词:

摘要: Owing to late diagnosis in advanced disease stages, prognosis of patients with epithelial ovarian cancer (EOC) is poor. The quantification deregulated levels microRNAs could facilitate earlier and improve EOC. Seven (miR-7, miR-16, miR-25, miR-93, miR-182, miR-376a miR-429) were quantified the serum 180 EOC 66 healthy women by TaqMan PCR microRNA assays. Median follow-up time was 21 months. effects miR-7 miR-429 on apoptosis, cell proliferation, migration invasion investigated two lines. Serum miR-25 (P=0.0001) miR-93 downregulated, whereas those (P=0.001) upregulated compared women. four discriminated from a sensitivity 93% specificity 92%. positively correlated CA125 values differed between FIGO I–II III–IV stages (P=0.001). MiR-429 an independent predictor overall survival (P=0.011). Overexpressed SKOV3 cells led suppression (P=0.037) Increased associated lymph node metastases (P=0.0001). resulted increased Additionally, (P=0.02). Our data indicate diagnostic potential miR-7, prognostic miR-429. This panel may be promising molecules targeted treatment

参考文章(44)
U. Wagner, P. Harter, F. Hilpert, S. Mahner, A. Reuß, A. du Bois, E. Petru, W. Meier, P. Ortner, K. König, K. Lindel, D. Grab, P. Piso, O. Ortmann, I. Runnebaum, J. Pfisterer, D. Lüftner, N. Frickhofen, F. Grünwald, B. Maier, J. Diebold, S. Hauptmann, F. Kommoss, G. Emons, B. Radeleff, M. Gebhardt, N. Arnold, G. Calaminus, I. Weisse, J. Weis, J. Sehouli, D. Fink, A. Burges, A. Hasenburg, C. Eggert, S3-Guideline on Diagnostics, Therapy and Follow-up of Malignant Ovarian Tumours Geburtshilfe Und Frauenheilkunde. ,vol. 73, pp. 874- 889 ,(2013) , 10.1055/S-0033-1350713
Wei Ge, De-cai Yu, Qing-guo Li, Xi Chen, Chen-yu Zhang, Yi-tao Ding, Expression of serum miR-16, let-7f, and miR-21 in patients with hepatocellular carcinoma and their clinical significances. Clinical Laboratory. ,vol. 60, pp. 427- ,(2014) , 10.7754/CLIN.LAB.2013.130133
Isabel Stückrath, Brigitte Rack, Wolfgang Janni, Bernadette Jäger, Klaus Pantel, Heidi Schwarzenbach, Aberrant plasma levels of circulating miR-16, miR-107, miR-130a and miR-146a are associated with lymph node metastasis and receptor status of breast cancer patients. Oncotarget. ,vol. 6, pp. 13387- 13401 ,(2015) , 10.18632/ONCOTARGET.3874
Corinna Eichelser, Isabel Stückrath, Volkmar Müller, Karin Milde-Langosch, Harriet Wikman, Klaus Pantel, Heidi Schwarzenbach, Increased serum levels of circulating exosomal microRNA-373 in receptor-negative breast cancer patients. Oncotarget. ,vol. 5, pp. 9650- 9663 ,(2014) , 10.18632/ONCOTARGET.2520
Alfons Navarro, Tania Díaz, Natalia Tovar, Fabiola Pedrosa, Rut Tejero, María Teresa Cibeira, Laura Magnano, Laura Rosiñol, Mariano Monzó, Joan Bladé, Carlos Fernández de Larrea, A serum microRNA signature associated with complete remission and progression after autologous stem-cell transplantation in patients with multiple myeloma Oncotarget. ,vol. 6, pp. 1874- 1883 ,(2015) , 10.18632/ONCOTARGET.2761
Heidi Schwarzenbach, Dave S. B. Hoon, Klaus Pantel, Cell-free nucleic acids as biomarkers in cancer patients Nature Reviews Cancer. ,vol. 11, pp. 426- 437 ,(2011) , 10.1038/NRC3066
Richard J Simpson, Justin WE Lim, Robert L Moritz, Suresh Mathivanan, Exosomes: proteomic insights and diagnostic potential Expert Review of Proteomics. ,vol. 6, pp. 267- 283 ,(2009) , 10.1586/EPR.09.17
B-S Li, Q-F Zuo, Y-L Zhao, B Xiao, Y Zhuang, X-H Mao, C Wu, S-M Yang, H Zeng, Q-M Zou, G Guo, MicroRNA-25 promotes gastric cancer migration, invasion and proliferation by directly targeting transducer of ERBB2, 1 and correlates with poor survival. Oncogene. ,vol. 34, pp. 2556- 2565 ,(2015) , 10.1038/ONC.2014.214
Philip A. Gregory, Andrew G. Bert, Emily L. Paterson, Simon C. Barry, Anna Tsykin, Gelareh Farshid, Mathew A. Vadas, Yeesim Khew-Goodall, Gregory J. Goodall, The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1 Nature Cell Biology. ,vol. 10, pp. 593- 601 ,(2008) , 10.1038/NCB1722